viewJudges Scientific PLC

Judges Scientific sees strong trading during first half


Scientific instruments maker Judges Scientific (LON:JDG) said it continued to trade strongly during its first half and that interim results are expected to show “solid organic growth” of 13 percent in its revenues during the six months to 30 June.

The firm said that revenue growth actually increased by 27 percent when businesses purchased since 1 January 2010 are taken into account, including a full six months turnover from Sircal (a maker of purification systems for use in metals analysis) and a first-time contribution from Deben (a microscope technology business), in which it has a 51 percent interest.

Judges added that interim profits and earnings per share, before exceptional items, “will be consistent at this stage with market expectations for the full year”.

Order intake during the first half showed organic growth of 2.3 percent, “albeit somewhat unevenly across the group”. The order book at 30 June represented 2.5 months of sales, which is similar to the level at the beginning of the year.

Recently, Judges’ UHV Design vacuum components subsidiary won the Queen’s Award for Enterprise in recognition of strong export achievements. Judges has purchased more land adjacent to UHV Design’s existing factory in order to expand this business’s operations.

The firm said that its balance sheet will show health cash surpluses at 30 June.

It added that although the global economic climate remains unreliable, with public spending under pressure in the developed world, "the group is well equipped to face these challenges with its broadly-based portfolio of resilient businesses".

Quick facts: Judges Scientific PLC

Price: 5050 GBX

Market: AIM
Market Cap: £314.34 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Akerna 'widening its competitive moat' with rollup strategy...

Akerna Corp (NASDAQ:KERN) CEO Jessica Billingsley tells Proactive the Denver, Colorado-based cannabis-focused regulatory compliance technology company is looking to 'widen its competitive moat' with recent investment into anti-counterfeit technology platform solo sciences inc. Billingsley...

21 minutes ago

2 min read